Decipher GRID Study Identifies Prostate Cancer Biomarkers

Decipher GRID Study Identifies Prostate Cancer Biomarkers
GenomeDx Biosciences has recently announced the publication of a new study titled “Characterization of 1,577 primary prostate cancers reveals novel biological and clinicopathologic insights into molecular subtypes”  utilizing Decipher GRID technology. Decipher GRID is a genomics database that can be used to identify subtypes of prostate cancer. The assay identifies prostate cancer biomarkers, including ERG, a biomarker that indicates whether a patient could be

Knowledge is power when living with prostate cancer.

Get access to the web’s leading Prostate Cancer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *